104 results
8-K
EX-10.1
CKPT
Checkpoint Therapeutics Inc
14 May 24
Departure of Directors or Certain Officers
7:30am
: (i) outstanding Options, SARs, and other Awards in the nature of rights that may be exercised shall become fully exercisable, (ii) time-based … , the Committee may in its sole discretion at any time determine that all or a portion of a Participant’s Options, SARs, and other Awards in the nature
D
2h1sd
5 Feb 24
Exempt offering of security
5:00pm
424B5
56ndvupareabwwgwz1l1
30 Jan 24
Prospectus supplement for primary offering
5:10pm
8-K
EX-10.1
6s20ryql7o6svmc7 4q
30 Jan 24
Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
5:00pm
8-K
EX-10.1
grwzy 5cdogs4s
31 Jul 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market
8:28am
424B5
zp5zfl03nuvwjmz3 8mu
31 Jul 23
Prospectus supplement for primary offering
8:23am
8-K
EX-10.1
au8dj kj1
13 Jun 23
Departure of Directors or Certain Officers
7:00am
424B5
vqakoncp11nwyb9i4
24 May 23
Prospectus supplement for primary offering
5:25pm
8-K
EX-10.1
khpzqtp
24 May 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:24pm
D
ro8 boiacc
14 Apr 23
Indefinite amount in options / securities to be acquired, 9 investors
5:00pm
8-K
EX-10.1
i2hyhk19
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am